Disseminated Intravascular coagulation in solid and hematological cancers
Introduction There is a clear relationship between malignancy and deranged coagulation. Patients with cancer are at...
Thrombosis and cancer
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer
Cancer is a well-known risk factor for the occurrence of venous thromboembolism. In contrast, little research has been...
Lessons from the CATCH study: beware of the risk of bleeding in neoplastic patients treated for VTE
The results of an interesting secondary analysis of the CATCH study were published recently and they are useful for a...
Rapping about new anticoagulants for CAT at ICTHIC 2018
Rapping about new anticoagulants for CAT at ICTHIC 2018 Cancer patients are four or five times as likely to develop...
Anticoagulant treatment in patients with thrombocytopenia and cancer-associated thrombosis
One of the most complex situations in the treatment of cancer-associated thrombosis is represented by oncological...
Arterial thromboembolism can also be the first clinical manifestation of a neoplasm
Several studies showed that venous thrombosis can be the first clinical manifestation of an occult neoplasm. For this...
The management of cancer patients with hemostatic disorders (thrombosis and/or bleeding) faces many clinical challenges
The management of cancer patients with hemostatic disorders (thrombosis and/or bleeding) faces many clinical...
The conundrum of anti-angiogenesis in cancer
“Anti-angiogenesis in cancer is something of a conundrum where the unexpected is to be expected.”...
Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer
The authors of a recent study1 have taken a novel look at the impact of venous thromboembolism (VTE) among...
CAT Studies
The following list contains a selection of the most recent clinical trials about cancer-associated thrombosis....